DRIP Score: Evaluates risk for multi-drug resistant (MDR) pneumonia pathogens. Aids in antibiotic stewardship by avoiding excessive broad-spectrum coverage.
MDR Pathogen Profile
Pathogen likely drug-susceptible (NPV >90%). Narrow-spectrum therapy appropriate.
Verified
Last Review: 2026-07-17
| Score < 4 | Low risk for drug-resistant pathogen (NPV >90%). Consider narrow-spectrum therapy. |
| Score ≥ 4 | High risk for drug-resistant pathogen. Consider broad-spectrum MRSA/Pseudomonas coverage. |
Webb BJ et al. • Clin Infect Dis.. 2016;62(9):1117-23. Established DRIP as a more accurate alternative to the HCAP criteria.
Last Comprehensive Review: 2026-07-17
Clinical Context
We think this has broad domain relevance to Drug-Resistant Pneumonia (DRIP) Score.
Clinical Context
We think this might be relevant to the clinical guidance for Drug-Resistant Pneumonia (DRIP) Score.
Clinical Context
We think this might be relevant to the clinical guidance for Drug-Resistant Pneumonia (DRIP) Score.
